India Exchange Filings

Wanbury Q2 FY27 Earnings Summary

Wanbury Ltd reports Q2 FY27 results, with standalone revenue up 14.3% to ₹182.9 crore

  • Standalone EBITDA margin was 14.3%, down 190 bps year on year; PAT fell 21.7% to ₹11.9 crore, attributed to a deferred tax provision.
  • Consolidated EBITDA was ₹22.9 crore and PAT ₹8.5 crore; results included a ₹3.4 crore loss at Wanbury Skin Health Ltd.
  • Results for the quarter ended 30 September 2026 are unaudited.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.